Swiss National Bank - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 129 filers reported holding CARA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$484,126
-59.1%
98,600
-10.5%
0.00%
-100.0%
Q4 2022$1,183,548
+17.1%
110,200
+2.0%
0.00%0.0%
Q3 2022$1,011,000
+4.3%
108,000
+1.8%
0.00%0.0%
Q2 2022$969,000
-21.1%
106,100
+4.9%
0.00%0.0%
Q1 2022$1,228,000
+14.6%
101,100
+14.9%
0.00%0.0%
Q4 2021$1,072,000
-21.2%
88,0000.0%0.00%0.0%
Q3 2021$1,360,000
+8.3%
88,0000.0%0.00%0.0%
Q2 2021$1,256,000
-46.5%
88,000
-18.7%
0.00%
-50.0%
Q1 2021$2,349,000
+54.0%
108,200
+7.3%
0.00%
+100.0%
Q4 2020$1,525,000
+18.9%
100,8000.0%0.00%0.0%
Q3 2020$1,283,000
-24.2%
100,800
+1.8%
0.00%0.0%
Q2 2020$1,693,000
+57.2%
99,000
+21.5%
0.00%0.0%
Q1 2020$1,077,000
-16.6%
81,500
+1.6%
0.00%0.0%
Q4 2019$1,292,000
-7.6%
80,200
+4.8%
0.00%0.0%
Q3 2019$1,398,000
-1.5%
76,500
+15.9%
0.00%
-50.0%
Q2 2019$1,419,000
+18.3%
66,000
+8.0%
0.00%
+100.0%
Q1 2019$1,199,000
+56.1%
61,100
+3.4%
0.00%0.0%
Q4 2018$768,000
-42.9%
59,100
+5.3%
0.00%0.0%
Q3 2018$1,344,000
+47.2%
56,100
+17.6%
0.00%0.0%
Q2 2018$913,000
+54.5%
47,7000.0%0.00%0.0%
Q1 2018$591,000
+14.1%
47,700
+12.8%
0.00%0.0%
Q4 2017$518,000
-10.5%
42,3000.0%0.00%0.0%
Q3 2017$579,000
-11.1%
42,3000.0%0.00%0.0%
Q2 2017$651,000
+257.7%
42,300
+40.5%
0.00%
Q1 2016$182,000
-57.0%
30,100
+19.9%
0.00%
-100.0%
Q4 2015$423,00025,1000.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,647,473$24,780,0002.96%
Chescapmanager LLC 1,160,392$10,861,0002.53%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,333,000$12,477,0001.60%
Altium Capital Management LP 193,000$1,806,0000.66%
DISCIPLINED GROWTH INVESTORS INC /MN 1,700,230$15,914,0000.44%
ALPINE WOODS CAPITAL INVESTORS, LLC 171,423$1,605,0000.22%
Lisanti Capital Growth, LLC 159,225$1,490,0000.20%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 72,529$679,0000.15%
PINNACLE ASSOCIATES LTD 705,367$6,602,0000.15%
FARALLON CAPITAL MANAGEMENT LLC 2,500,000$23,400,0000.13%
View complete list of CARA THERAPEUTICS INC shareholders